nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0726	0.126	CbGbCtD
Alfuzosin—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0682	0.119	CbGbCtD
Alfuzosin—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0682	0.119	CbGbCtD
Alfuzosin—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0617	0.107	CbGbCtD
Alfuzosin—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0617	0.107	CbGbCtD
Alfuzosin—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0533	0.0925	CbGbCtD
Alfuzosin—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0517	0.0898	CbGbCtD
Alfuzosin—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0468	0.0812	CbGbCtD
Alfuzosin—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0468	0.0812	CbGbCtD
Alfuzosin—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0448	0.0779	CbGbCtD
Alfuzosin—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000497	0.00117	CcSEcCtD
Alfuzosin—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000496	0.00117	CcSEcCtD
Alfuzosin—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000495	0.00117	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000495	0.00117	CcSEcCtD
Alfuzosin—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000494	0.00117	CcSEcCtD
Alfuzosin—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000494	0.00116	CcSEcCtD
Alfuzosin—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000493	0.00116	CcSEcCtD
Alfuzosin—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000492	0.00116	CcSEcCtD
Alfuzosin—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000492	0.00116	CcSEcCtD
Alfuzosin—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000492	0.00116	CcSEcCtD
Alfuzosin—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000491	0.00116	CcSEcCtD
Alfuzosin—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00049	0.00116	CcSEcCtD
Alfuzosin—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00049	0.00116	CcSEcCtD
Alfuzosin—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00049	0.00116	CcSEcCtD
Alfuzosin—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.00049	0.00115	CcSEcCtD
Alfuzosin—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000489	0.00115	CcSEcCtD
Alfuzosin—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000488	0.00115	CcSEcCtD
Alfuzosin—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000487	0.00115	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000486	0.00114	CcSEcCtD
Alfuzosin—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000485	0.00114	CcSEcCtD
Alfuzosin—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000483	0.00114	CcSEcCtD
Alfuzosin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000483	0.00114	CcSEcCtD
Alfuzosin—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000483	0.00114	CcSEcCtD
Alfuzosin—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000482	0.00114	CcSEcCtD
Alfuzosin—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.00048	0.00113	CcSEcCtD
Alfuzosin—Rash—Didanosine—acquired immunodeficiency syndrome	0.000479	0.00113	CcSEcCtD
Alfuzosin—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000479	0.00113	CcSEcCtD
Alfuzosin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000479	0.00113	CcSEcCtD
Alfuzosin—Headache—Didanosine—acquired immunodeficiency syndrome	0.000476	0.00112	CcSEcCtD
Alfuzosin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000475	0.00112	CcSEcCtD
Alfuzosin—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000474	0.00112	CcSEcCtD
Alfuzosin—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000474	0.00112	CcSEcCtD
Alfuzosin—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000474	0.00112	CcSEcCtD
Alfuzosin—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000473	0.00112	CcSEcCtD
Alfuzosin—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000472	0.00111	CcSEcCtD
Alfuzosin—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000472	0.00111	CcSEcCtD
Alfuzosin—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000472	0.00111	CcSEcCtD
Alfuzosin—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000471	0.00111	CcSEcCtD
Alfuzosin—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00047	0.00111	CcSEcCtD
Alfuzosin—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000469	0.00111	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000469	0.00111	CcSEcCtD
Alfuzosin—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000468	0.0011	CcSEcCtD
Alfuzosin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000468	0.0011	CcSEcCtD
Alfuzosin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000467	0.0011	CcSEcCtD
Alfuzosin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000467	0.0011	CcSEcCtD
Alfuzosin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000466	0.0011	CcSEcCtD
Alfuzosin—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000466	0.0011	CcSEcCtD
Alfuzosin—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000465	0.0011	CcSEcCtD
Alfuzosin—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000465	0.0011	CcSEcCtD
Alfuzosin—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000465	0.0011	CcSEcCtD
Alfuzosin—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000462	0.00109	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000462	0.00109	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00046	0.00108	CcSEcCtD
Alfuzosin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00046	0.00108	CcSEcCtD
Alfuzosin—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00046	0.00108	CcSEcCtD
Alfuzosin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000459	0.00108	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000459	0.00108	CcSEcCtD
Alfuzosin—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000458	0.00108	CcSEcCtD
Alfuzosin—Pain—Indinavir—acquired immunodeficiency syndrome	0.000456	0.00107	CcSEcCtD
Alfuzosin—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000456	0.00107	CcSEcCtD
Alfuzosin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000455	0.00107	CcSEcCtD
Alfuzosin—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000455	0.00107	CcSEcCtD
Alfuzosin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000453	0.00107	CcSEcCtD
Alfuzosin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000453	0.00107	CcSEcCtD
Alfuzosin—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000452	0.00107	CcSEcCtD
Alfuzosin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000451	0.00106	CcSEcCtD
Alfuzosin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000451	0.00106	CcSEcCtD
Alfuzosin—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00045	0.00106	CcSEcCtD
Alfuzosin—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00045	0.00106	CcSEcCtD
Alfuzosin—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.00045	0.00106	CcSEcCtD
Alfuzosin—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000448	0.00106	CcSEcCtD
Alfuzosin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000447	0.00105	CcSEcCtD
Alfuzosin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000447	0.00105	CcSEcCtD
Alfuzosin—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000446	0.00105	CcSEcCtD
Alfuzosin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000445	0.00105	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000444	0.00105	CcSEcCtD
Alfuzosin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000443	0.00105	CcSEcCtD
Alfuzosin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000442	0.00104	CcSEcCtD
Alfuzosin—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000441	0.00104	CcSEcCtD
Alfuzosin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000439	0.00104	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000439	0.00104	CcSEcCtD
Alfuzosin—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000438	0.00103	CcSEcCtD
Alfuzosin—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000438	0.00103	CcSEcCtD
Alfuzosin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000437	0.00103	CcSEcCtD
Alfuzosin—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000437	0.00103	CcSEcCtD
Alfuzosin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000436	0.00103	CcSEcCtD
Alfuzosin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000436	0.00103	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000436	0.00103	CcSEcCtD
Alfuzosin—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000435	0.00103	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000435	0.00103	CcSEcCtD
Alfuzosin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000434	0.00102	CcSEcCtD
Alfuzosin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000434	0.00102	CcSEcCtD
Alfuzosin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000433	0.00102	CcSEcCtD
Alfuzosin—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000431	0.00102	CcSEcCtD
Alfuzosin—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000431	0.00102	CcSEcCtD
Alfuzosin—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000431	0.00102	CcSEcCtD
Alfuzosin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000431	0.00102	CcSEcCtD
Alfuzosin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00043	0.00101	CcSEcCtD
Alfuzosin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00043	0.00101	CcSEcCtD
Alfuzosin—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000429	0.00101	CcSEcCtD
Alfuzosin—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000428	0.00101	CcSEcCtD
Alfuzosin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000428	0.00101	CcSEcCtD
Alfuzosin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000427	0.00101	CcSEcCtD
Alfuzosin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000427	0.00101	CcSEcCtD
Alfuzosin—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000426	0.001	CcSEcCtD
Alfuzosin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000424	0.001	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000424	0.000999	CcSEcCtD
Alfuzosin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000423	0.000998	CcSEcCtD
Alfuzosin—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000422	0.000995	CcSEcCtD
Alfuzosin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000422	0.000994	CcSEcCtD
Alfuzosin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000421	0.000993	CcSEcCtD
Alfuzosin—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000421	0.000992	CcSEcCtD
Alfuzosin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000421	0.000992	CcSEcCtD
Alfuzosin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00042	0.00099	CcSEcCtD
Alfuzosin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000419	0.000989	CcSEcCtD
Alfuzosin—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000417	0.000984	CcSEcCtD
Alfuzosin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000417	0.000983	CcSEcCtD
Alfuzosin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000417	0.000982	CcSEcCtD
Alfuzosin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000417	0.000982	CcSEcCtD
Alfuzosin—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000416	0.000982	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000416	0.000981	CcSEcCtD
Alfuzosin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000416	0.00098	CcSEcCtD
Alfuzosin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000415	0.000979	CcSEcCtD
Alfuzosin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000415	0.000979	CcSEcCtD
Alfuzosin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000415	0.000978	CcSEcCtD
Alfuzosin—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000415	0.000978	CcSEcCtD
Alfuzosin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000414	0.000977	CcSEcCtD
Alfuzosin—Headache—Stavudine—acquired immunodeficiency syndrome	0.000413	0.000974	CcSEcCtD
Alfuzosin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000413	0.000974	CcSEcCtD
Alfuzosin—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000412	0.000972	CcSEcCtD
Alfuzosin—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000412	0.000972	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000412	0.000971	CcSEcCtD
Alfuzosin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000411	0.00097	CcSEcCtD
Alfuzosin—Rash—Abacavir—acquired immunodeficiency syndrome	0.00041	0.000966	CcSEcCtD
Alfuzosin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000409	0.000965	CcSEcCtD
Alfuzosin—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000409	0.000965	CcSEcCtD
Alfuzosin—Headache—Abacavir—acquired immunodeficiency syndrome	0.000407	0.00096	CcSEcCtD
Alfuzosin—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000407	0.000958	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000406	0.000957	CcSEcCtD
Alfuzosin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000406	0.000956	CcSEcCtD
Alfuzosin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000406	0.000956	CcSEcCtD
Alfuzosin—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000403	0.000949	CcSEcCtD
Alfuzosin—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000401	0.000946	CcSEcCtD
Alfuzosin—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000401	0.000945	CcSEcCtD
Alfuzosin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000401	0.000945	CcSEcCtD
Alfuzosin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.0004	0.000943	CcSEcCtD
Alfuzosin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000398	0.000939	CcSEcCtD
Alfuzosin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000397	0.000937	CcSEcCtD
Alfuzosin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000397	0.000936	CcSEcCtD
Alfuzosin—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000396	0.000934	CcSEcCtD
Alfuzosin—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000396	0.000933	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000394	0.000929	CcSEcCtD
Alfuzosin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000393	0.000926	CcSEcCtD
Alfuzosin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000392	0.000925	CcSEcCtD
Alfuzosin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000392	0.000925	CcSEcCtD
Alfuzosin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000392	0.000924	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000391	0.000921	CcSEcCtD
Alfuzosin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000386	0.00091	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000385	0.000907	CcSEcCtD
Alfuzosin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000384	0.000906	CcSEcCtD
Alfuzosin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000383	0.000903	CcSEcCtD
Alfuzosin—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000382	0.000902	CcSEcCtD
Alfuzosin—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000382	0.000901	CcSEcCtD
Alfuzosin—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000381	0.000899	CcSEcCtD
Alfuzosin—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000381	0.000898	CcSEcCtD
Alfuzosin—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000381	0.000898	CcSEcCtD
Alfuzosin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000381	0.000898	CcSEcCtD
Alfuzosin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000379	0.000894	CcSEcCtD
Alfuzosin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000378	0.00089	CcSEcCtD
Alfuzosin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000377	0.000889	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000373	0.000879	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00037	0.000873	CcSEcCtD
Alfuzosin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00037	0.000872	CcSEcCtD
Alfuzosin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000367	0.000866	CcSEcCtD
Alfuzosin—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000367	0.000865	CcSEcCtD
Alfuzosin—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000367	0.000865	CcSEcCtD
Alfuzosin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000365	0.00086	CcSEcCtD
Alfuzosin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000364	0.000859	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000364	0.000859	CcSEcCtD
Alfuzosin—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000364	0.000858	CcSEcCtD
Alfuzosin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000361	0.000852	CcSEcCtD
Alfuzosin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000361	0.000852	CcSEcCtD
Alfuzosin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000361	0.000851	CcSEcCtD
Alfuzosin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.00036	0.000849	CcSEcCtD
Alfuzosin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000359	0.000847	CcSEcCtD
Alfuzosin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000356	0.00084	CcSEcCtD
Alfuzosin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000354	0.000835	CcSEcCtD
Alfuzosin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000353	0.000833	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000353	0.000833	CcSEcCtD
Alfuzosin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000353	0.000832	CcSEcCtD
Alfuzosin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000353	0.000831	CcSEcCtD
Alfuzosin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000352	0.000831	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000351	0.000827	CcSEcCtD
Alfuzosin—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00035	0.000825	CcSEcCtD
Alfuzosin—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00035	0.000825	CcSEcCtD
Alfuzosin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000346	0.000815	CcSEcCtD
Alfuzosin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000345	0.000812	CcSEcCtD
Alfuzosin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000341	0.000804	CcSEcCtD
Alfuzosin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000341	0.000803	CcSEcCtD
Alfuzosin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00034	0.000803	CcSEcCtD
Alfuzosin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000339	0.000799	CcSEcCtD
Alfuzosin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000339	0.000799	CcSEcCtD
Alfuzosin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000337	0.000795	CcSEcCtD
Alfuzosin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000336	0.000792	CcSEcCtD
Alfuzosin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000336	0.000792	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000335	0.000789	CcSEcCtD
Alfuzosin—Headache—Indinavir—acquired immunodeficiency syndrome	0.000334	0.000787	CcSEcCtD
Alfuzosin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000333	0.000785	CcSEcCtD
Alfuzosin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00033	0.000777	CcSEcCtD
Alfuzosin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000325	0.000766	CcSEcCtD
Alfuzosin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000323	0.000763	CcSEcCtD
Alfuzosin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00032	0.000755	CcSEcCtD
Alfuzosin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00032	0.000754	CcSEcCtD
Alfuzosin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000319	0.000751	CcSEcCtD
Alfuzosin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000318	0.000749	CcSEcCtD
Alfuzosin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000317	0.000748	CcSEcCtD
Alfuzosin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000317	0.000746	CcSEcCtD
Alfuzosin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000316	0.000744	CcSEcCtD
Alfuzosin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000315	0.000743	CcSEcCtD
Alfuzosin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000308	0.000726	CcSEcCtD
Alfuzosin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000306	0.000722	CcSEcCtD
Alfuzosin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000305	0.000719	CcSEcCtD
Alfuzosin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000304	0.000716	CcSEcCtD
Alfuzosin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000304	0.000716	CcSEcCtD
Alfuzosin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000303	0.000715	CcSEcCtD
Alfuzosin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000302	0.000712	CcSEcCtD
Alfuzosin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000299	0.000705	CcSEcCtD
Alfuzosin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000295	0.000695	CcSEcCtD
Alfuzosin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000294	0.000692	CcSEcCtD
Alfuzosin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000293	0.000692	CcSEcCtD
Alfuzosin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000289	0.000682	CcSEcCtD
Alfuzosin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000286	0.000675	CcSEcCtD
Alfuzosin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000284	0.000669	CcSEcCtD
Alfuzosin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000283	0.000668	CcSEcCtD
Alfuzosin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000281	0.000662	CcSEcCtD
Alfuzosin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000281	0.000662	CcSEcCtD
Alfuzosin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00028	0.00066	CcSEcCtD
Alfuzosin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000279	0.000658	CcSEcCtD
Alfuzosin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000273	0.000643	CcSEcCtD
Alfuzosin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000271	0.000638	CcSEcCtD
Alfuzosin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.000638	CcSEcCtD
Alfuzosin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.000637	CcSEcCtD
Alfuzosin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000269	0.000633	CcSEcCtD
Alfuzosin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000265	0.000624	CcSEcCtD
Alfuzosin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00026	0.000613	CcSEcCtD
Alfuzosin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.000608	CcSEcCtD
Alfuzosin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.000608	CcSEcCtD
Alfuzosin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000256	0.000604	CcSEcCtD
Alfuzosin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000255	0.000601	CcSEcCtD
Alfuzosin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000243	0.000573	CcSEcCtD
